clinical trial · NCT01016834
Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
Zogenix, Inc.·phase4·completed·n = 246
MigraineSumavel DoseProSumatriptan
brief summary
The purpose of the study is to evaluate the treatment satisfaction of subjects using Sumavel DosePro to treat their moderate to severe migraines.
started
Nov 30, 2009
primary completion
Apr 30, 2010
completion
Apr 30, 2010
last updated
Jun 8, 2026
detailed description
Single arm, open-label, multicenter study to evaluate the treatment satisfaction, treatment confidence, and subject preference for Sumavel DosePro in adult subjects diagnosed with migraines and currently treated with triptans. Subjects will treat up to 4 migraines over a 60 day period and complete migraine diaries and questionnaires.
official title
A Multicenter, Open-label Evaluation of Treatment Satisfaction, Tolerability, Safety and Preference for Sumavel DosePro for Treatment of Migraine in Subjects Currently Treated With Triptans
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol